Growing Financial Burden From High-Cost Targeted Oral Anticancer Medicines Among Medicare Beneficiaries With Cancer.
Meng LiKaiping LiaoI-Wen PanYa Chen Tina ShihPublished in: JCO oncology practice (2022)
The high and growing burden from TOAMs highlighted the need for reining in drug prices and capping out-of-pocket spending.